Journal of Cystic Fibrosis
Volume 4, Issue 3 , Pages 205-207 , September 2005

MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?

  • D.G. Downey

      Affiliations

    • Adult Cystic Fibrosis Unit, Brisbane, QLD, Australia
    • ,
  • T.J. Kidd

      Affiliations

    • Queensland Health Pathology Services, The Prince Charles Hospital, Brisbane, QLD, Australia
    • ,
  • C. Coulter

      Affiliations

    • Queensland Health Pathology Services, The Prince Charles Hospital, Brisbane, QLD, Australia
    • ,
  • S.C. Bell

      Affiliations

    • Adult Cystic Fibrosis Unit, Brisbane, QLD, Australia
    • Department of Medicine, University of Queensland, Brisbane, Australia
    • Corresponding Author InformationCorresponding author. Department of Thoracic Medicine, The Prince Charles Hospital, Rode Road, Chermside, QLD 4032, Australia. Tel.: +61 7 3350 8770; fax: +61 7 3212 5630.

References 

  1. Jevons MP. “Celbenin” resistant Staphylococci. BMJ. 1961;1:124–125
  2. Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol. 1992;13:725–737
  3. Thomas SR, Gyi KM, Gaya H, Hodson ME. Methicillin resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect. 1998;40:203–209
  4. Cystic Fibrosis Foundation Patient Registry Annual Data Report, 2002. Bethesda, MD: September 2003.
  5. Walters S. Association of cystic fibrosis adults survey 1994. UK: Cystic Fibrosis Trust; 1995;
  6. Walters S. Cystic fibrosis trust. Health care workers with cystic fibrosis. UK: Cystic Fibrosis Trust; 2002;
  7. Combined Working Party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association . Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect. 1998;39:253–290
  8. Nimmo GR, Bell JM, Mitchell D, Gosbell IB, Pearman JW, Turnbridge JD. AGAR. Resistance to Staphylococcus aureus in Australian teaching hospitals, 1989–1999. Microb Drug Resist. 2003;9:155–160
  9. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239
  10. Hershow RC, Khayr WF, Smith NL. A comparison of clinical virulence of nocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol. 1992;13:587–593
  11. Boxerbaum B, Jacobs MR, Cechner RL. Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatr Pulmonol. 1998;4:159–163
  12. MacKenzie D, Edwards A. MRSA: the psychological effects. Nurs Stand. 1997;12:49–56
  13. Govan JRW. Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex. J R Soc Med. 2000;93(Suppl. 38):40–45
  14. Kidd TJ, Coulter C, Bell SC. An epidemiological analysis of methicillin-resistant Staphylococcus aureus (MRSA) among adult patients with cystic fibrosis. Infect Control Hosp Epidemiol. In press.
  15. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593–598
  16. Serisier DJ, Jones G, Carroll M. Eradication of pulmonary methicillin-resistant Staphylococcal aureus (MRSA) in cystic fibrosis with linezolid. J Cyst Fibros. 2004;3:61
  17. Ferrin M, Zuckerman JB, Meagher A, Blumberg EA. Successful treatment methicillin-resistant Staphylococcal aureus pulmonary infection with linezolid in a patient with cystic fibrosis. Pediatr Pulmonol. 2002;33:221–223
  18. Solis A, Brown D, Hughes J, Van Saene HK, Heaf DP. Methicillin-resistant Staphylococcal aureus in children with cystic fibrosis: an eradication protocol. Pediatr Pulmonol. 2003;36:189–195
  19. Garske LA, Kidd TJ, Gan R, Bunting JP, Franks CA, Coulter C, et al. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection. J Hosp Infect. 2004;56:208–214

PII: S1569-1993(05)00072-X

doi: 10.1016/j.jcf.2005.05.014

Journal of Cystic Fibrosis
Volume 4, Issue 3 , Pages 205-207 , September 2005

Article Tools

* Image Usage & Resolution